Delivery Order SPE2DR25D7909-SPE2DR26FX7FL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,359.71 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 Gram/10 mL vials (10 mL quantity). This firm fixed-price delivery order, issued on January 16, 2026, carries an ultimate completion date of January 20, 2026, and was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Procainamide 1 gram/10 milliliter vials totaling $9,116.21 with an ultimate completion date of January 30, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, where the product will be...
- The Defense Logistics Agency awarded a $2,251.23 delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 9, 2026, for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order is scheduled for completion by January 12, 2026, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order valued at $1,566.00 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order, awarded on January 29, 2026, has an ultimate completion date of January 30, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive set-aside contract, reflecting the contractor's established capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $2,512.96 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on a firm fixed-price basis. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive delivery order under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency awarded a delivery order valued at $2,998.81 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on January 28, 2026, with completion scheduled for January 29, 2026. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used in military and federal healthcare settings to...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.11 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on August 27, 2025. This firm fixed price delivery order, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $3,814.66 and an ultimate completion date of January 2, 2026. This is a firm fixed-price, non-set-aside contract with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D7909Indefinite Delivery Contract
- SPE2DR25D7909-SPE2DR26FX7FLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,146.22 to Amerisourcebergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order was not set aside for any particular business category and represents a competitive award to the prime contractor. The contract will be performed at Amerisourcebergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime contract vehicle enables Cencora/Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related commodities—to support military healthcare programs globally. The delivery order for Procainamide, a cardiac antiarrhythmic medication, exemplifies the types of essential pharmaceuticals distributed through this contract vehicle to support military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 1/28/26 |